BRPI0515163A - métodos para tratar hemoptise ou sangramento traqueal, brÈnquico ou alveolar local - Google Patents
métodos para tratar hemoptise ou sangramento traqueal, brÈnquico ou alveolar localInfo
- Publication number
- BRPI0515163A BRPI0515163A BRPI0515163-5A BRPI0515163A BRPI0515163A BR PI0515163 A BRPI0515163 A BR PI0515163A BR PI0515163 A BRPI0515163 A BR PI0515163A BR PI0515163 A BRPI0515163 A BR PI0515163A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- bronchial
- alveolar
- bleeding
- local
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
MéTODOS PARA TRATAR HEMOPTISE OU SANGRAMENTO TRAQUEAL, BRÈNQUICO OU ALVEOLAR LOCAL A presente invenção fornece métodos para o tratamento local de hemoptise ou sangramento alveolar, brónquico ou traqueal e/ou redução de efeitos não desejados associados com administração sistêmica de agentes trombóticos a um indivíduo por meio de administração intratraqueal, intrabrónquica ou intraalveolar de um fator de coagulação de sangue ao indivíduo.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60875904P | 2004-09-10 | 2004-09-10 | |
US62297704P | 2004-10-28 | 2004-10-28 | |
US69396905P | 2005-06-24 | 2005-06-24 | |
PCT/DK2005/000576 WO2006026998A1 (en) | 2004-09-10 | 2005-09-09 | Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0515163A true BRPI0515163A (pt) | 2008-07-08 |
Family
ID=35482229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0515163-5A BRPI0515163A (pt) | 2004-09-10 | 2005-09-09 | métodos para tratar hemoptise ou sangramento traqueal, brÈnquico ou alveolar local |
Country Status (13)
Country | Link |
---|---|
US (2) | US8431535B2 (pt) |
EP (1) | EP1791555B1 (pt) |
JP (2) | JP2008512403A (pt) |
KR (1) | KR101241434B1 (pt) |
AU (1) | AU2005282065B2 (pt) |
BR (1) | BRPI0515163A (pt) |
CA (1) | CA2579884C (pt) |
DK (1) | DK1791555T3 (pt) |
HK (1) | HK1104970A1 (pt) |
IL (1) | IL181824A (pt) |
MX (1) | MX2007002903A (pt) |
NO (1) | NO20071824L (pt) |
WO (1) | WO2006026998A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007002903A (es) | 2004-09-10 | 2007-07-11 | Pharmaorigin Aps | Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales. |
US8088728B2 (en) * | 2005-06-24 | 2012-01-03 | Drugrecure Aps | Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract |
WO2007092820A2 (en) | 2006-02-03 | 2007-08-16 | Lazarus Effect, Inc. | Methods and devices for restoring blood flow within blocked vasculature |
DK2004214T3 (da) | 2006-03-16 | 2013-02-18 | Stellaris Pharmaceuticals Aps | Lokalbehandling med faktor VII |
EP2403583B1 (en) | 2009-03-06 | 2016-10-19 | Lazarus Effect, Inc. | Retrieval systems |
US20120141467A1 (en) * | 2010-12-03 | 2012-06-07 | Schneider Daniel J | Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma |
US9301936B2 (en) | 2013-07-08 | 2016-04-05 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical formulations of tranexamic acid and their use |
CN107405470A (zh) | 2015-02-11 | 2017-11-28 | 柯惠有限合伙公司 | 带可扩张尖端的医疗装置和方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3920845A (en) * | 1971-08-03 | 1975-11-18 | Beecham Group Ltd | 2-nitroindan-1,3-dione |
US5096916A (en) | 1990-05-07 | 1992-03-17 | Aegis Technology, Inc. | Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline |
US5427797A (en) | 1993-04-06 | 1995-06-27 | Brigham And Women's Hospital | Systemic effects of nitric oxide inhalation |
US5690910A (en) * | 1995-08-18 | 1997-11-25 | Baker Norton Pharmaceuticals, Inc. | Method for treating asthma |
US5980865A (en) * | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
US5925738A (en) * | 1995-12-01 | 1999-07-20 | The American National Red Cross | Methods of production and use of liquid formulations of plasma proteins |
WO1998032459A1 (en) * | 1997-01-29 | 1998-07-30 | University Technology Corporation | Plasminogen activator as an anti-inflammatory agent |
KR100620338B1 (ko) * | 1998-03-16 | 2006-09-13 | 넥타르 테라퓨틱스 | 에어로졸형 활성 제제 전달 방법 |
ES2253003T3 (es) * | 1998-11-10 | 2006-05-16 | Altana Pharma Ag | Equipo de tratamiento que contiene composiciones a base de agentes tensioactivos pulmonares. |
EP1282438B1 (en) * | 2000-05-10 | 2005-08-03 | Novo Nordisk Health Care AG | Use of pharmaceutical composition comprising a factor viia and a factor xiii |
US7419949B2 (en) * | 2001-07-16 | 2008-09-02 | Novo Noridsk Healthcare A/G | Single-dose administration of factor VIIa |
WO2003039581A1 (en) * | 2001-11-09 | 2003-05-15 | Novo Nordisk Health Care Ag | Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid |
CA2475097C (en) * | 2002-02-04 | 2012-05-08 | Salpep Biotechnology Inc. | Anti-inflammatory peptides |
NZ536796A (en) * | 2002-04-25 | 2007-03-30 | Scripps Research Inst | Treatment and prevention of pulmonary conditions comprising at least one lung surfactant polypeptide and at least one protease inhibitor, lipase inhibitor or an anti-oxidant |
US7700733B2 (en) * | 2002-04-30 | 2010-04-20 | Bayer Healthcare Llc | Factor VII or VIIa polypeptide variants |
JP2007524607A (ja) * | 2003-04-09 | 2007-08-30 | ワイス | 凝固因子の吸入による血友病処置 |
US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
US7404957B2 (en) * | 2003-08-29 | 2008-07-29 | Aerovance, Inc. | Modified IL-4 mutein receptor antagonists |
MX2007002903A (es) | 2004-09-10 | 2007-07-11 | Pharmaorigin Aps | Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales. |
-
2005
- 2005-09-09 MX MX2007002903A patent/MX2007002903A/es active IP Right Grant
- 2005-09-09 DK DK05779096.6T patent/DK1791555T3/da active
- 2005-09-09 WO PCT/DK2005/000576 patent/WO2006026998A1/en active Application Filing
- 2005-09-09 EP EP05779096A patent/EP1791555B1/en active Active
- 2005-09-09 KR KR1020077008170A patent/KR101241434B1/ko active IP Right Grant
- 2005-09-09 AU AU2005282065A patent/AU2005282065B2/en not_active Ceased
- 2005-09-09 BR BRPI0515163-5A patent/BRPI0515163A/pt not_active IP Right Cessation
- 2005-09-09 CA CA2579884A patent/CA2579884C/en not_active Expired - Fee Related
- 2005-09-09 JP JP2007530584A patent/JP2008512403A/ja active Pending
- 2005-09-09 US US11/575,076 patent/US8431535B2/en not_active Expired - Fee Related
-
2006
- 2006-05-26 US US11/442,474 patent/US7807639B2/en not_active Expired - Fee Related
-
2007
- 2007-03-08 IL IL181824A patent/IL181824A/en not_active IP Right Cessation
- 2007-04-10 NO NO20071824A patent/NO20071824L/no not_active Application Discontinuation
- 2007-12-06 HK HK07113348.5A patent/HK1104970A1/xx not_active IP Right Cessation
-
2011
- 2011-12-22 JP JP2011280963A patent/JP5537537B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1791555B1 (en) | 2013-03-13 |
WO2006026998A1 (en) | 2006-03-16 |
DK1791555T3 (da) | 2013-06-10 |
US20070258971A1 (en) | 2007-11-08 |
KR20070067127A (ko) | 2007-06-27 |
US20070060517A1 (en) | 2007-03-15 |
US8431535B2 (en) | 2013-04-30 |
JP5537537B2 (ja) | 2014-07-02 |
WO2006026998A8 (en) | 2006-05-04 |
JP2012092131A (ja) | 2012-05-17 |
IL181824A (en) | 2012-05-31 |
CA2579884C (en) | 2013-12-31 |
CA2579884A1 (en) | 2006-03-16 |
IL181824A0 (en) | 2007-07-04 |
JP2008512403A (ja) | 2008-04-24 |
KR101241434B1 (ko) | 2013-03-12 |
MX2007002903A (es) | 2007-07-11 |
US7807639B2 (en) | 2010-10-05 |
AU2005282065B2 (en) | 2013-02-07 |
AU2005282065A1 (en) | 2006-03-16 |
NO20071824L (no) | 2007-04-10 |
HK1104970A1 (en) | 2008-02-01 |
EP1791555A1 (en) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0515163A (pt) | métodos para tratar hemoptise ou sangramento traqueal, brÈnquico ou alveolar local | |
CY1121135T1 (el) | Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος | |
ATE455463T1 (de) | Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren | |
BR112015016466A2 (pt) | método para o tratamento de câncer baseado no estado de mutação de k-ras | |
MX2008010222A (es) | Antibioticos nebulizados para terapia de inhalacion. | |
BRPI0716210A2 (pt) | Métodos, composições e aparelhos para tratar feridas com pressões diferentes da atmosférica | |
CR11731A (es) | Composiciones y procedimientos para su preparación y uso | |
WO2007143607A3 (en) | Method of treating atrophic vaginitis | |
BRPI0609393B8 (pt) | usos de um composto 11-desóxi-prostaglandina | |
MX351641B (es) | Composicion y aposito para tratamiento de heridas. | |
BRPI0806392A8 (pt) | uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica | |
BRPI0811387B8 (pt) | kit de administração de um surfactante pulmonar | |
BRPI0512841A (pt) | composições e métodos para o tratamento de infecções patológicas | |
ATE493969T1 (de) | Kombination aus fosfomycin/aminoglycosid in aerosolform zur behandlung bakterieller atemwegsinfektionen | |
BRPI0512503A (pt) | composição que compreende ácido lático e lactoferrina | |
AR077372A1 (es) | Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales | |
BR112013028786A2 (pt) | método e composição de tratamento de sementes | |
PH12019501469A1 (en) | Compositions and methods for treating biofilms | |
SG196863A1 (en) | Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage | |
DE602007010529D1 (de) | Vorrichtung zur Verabreichung von Sauerstoff oder damit angereicherter Luft für Atemwegstherapien | |
WO2006135493A3 (en) | A composition for wound healing and use thereof | |
WO2012051339A3 (en) | Methods and compositions for treating respiratory conditions using platelet enriched plasma | |
ATE475408T1 (de) | Formulierungen von tipifarnib zur intravenösen verabreichung | |
WO2009098464A3 (en) | Use of g-rich oligonucleotides for treating neoplastic diseases | |
WO2009006246A8 (en) | Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved |
Owner name: PHARMAORIGIN APS (DK) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018080040797/SP DE 27/06/2008. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |